Quantum Foods Expects FY2026 Headline Earnings Per Share to Rise 17%-29%
Bitget2026/10/27 15:02- Quantum Foods expects headline earnings per share of 157.5–173.7 cents for the year ended September 30, 2026, up 17%–29%.
- Earnings per share are forecast at 160–176.6 cents, up 16%–28% from 137.8 cents; prior-year headline earnings were 134.4 cents per share.
- Trading benefited from stronger poultry demand, a stronger rand and lower feed costs, partly offset by higher second-half fuel costs.
- Layer farming and other African businesses delivered significantly higher earnings, while broiler farming earnings fell on lower contracted sales margins.
- Egg earnings declined as average selling prices fell 5%, despite slightly higher volumes; feed business earnings improved.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
